General Information of the Compound
| Compound ID |
CP0873683
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-3-[3-(2-{[4-{4-[4-(2-fluoroethyl)-3-oxo-1-piperazinyl]-1-piperidinyl}-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C42H40F3N9O3
|
||||||||||||||||||
| Molecular Weight |
775.836
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(N2CCC(N3CCN(CCF)C(=O)C3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C42H40F3N9O3/c1-57-35-25-30(51-19-14-29(15-20-51)53-23-22-52(21-16-43)37(55)26-53)11-12-33(35)47-42-46-17-13-34(48-42)40-38(49-36-10-2-3-18-54(36)40)27-6-4-7-28(24-27)41(56)50-39-31(44)8-5-9-32(39)45/h2-13,17-18,24-25,29H,14-16,19-23,26H2,1H3,(H,50,56)(H,46,47,48)
Show/Hide
|
||||||||||||||||||
| InChIKey |
HZYBLRXYLBWBTC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor